Shares of KMG Chemicals, Inc. (NYSE:KMG) have been given a consensus recommendation of “Hold” by the seven ratings firms that are covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $79.00.

A number of equities analysts have recently issued reports on KMG shares. ValuEngine raised KMG Chemicals from a “hold” rating to a “buy” rating in a research report on Wednesday, October 24th. Seaport Global Securities downgraded KMG Chemicals from a “buy” rating to a “neutral” rating in a research report on Friday, September 14th. Fraser Mackenzie reissued a “buy” rating on shares of KMG Chemicals in a research report on Friday, November 2nd. Zacks Investment Research raised KMG Chemicals from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a research report on Thursday, October 4th. Finally, Gabelli downgraded KMG Chemicals from a “buy” rating to a “hold” rating in a research report on Thursday, August 16th.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Youngs Advisory Group Inc. grew its position in shares of KMG Chemicals by 3.0% during the 3rd quarter. Youngs Advisory Group Inc. now owns 32,013 shares of the specialty chemicals company’s stock worth $2,419,000 after buying an additional 936 shares in the last quarter. Metropolitan Life Insurance Co. NY boosted its position in KMG Chemicals by 24.7% during the second quarter. Metropolitan Life Insurance Co. NY now owns 5,300 shares of the specialty chemicals company’s stock valued at $391,000 after purchasing an additional 1,049 shares in the last quarter. Swiss National Bank boosted its position in KMG Chemicals by 9.0% during the second quarter. Swiss National Bank now owns 24,300 shares of the specialty chemicals company’s stock valued at $1,793,000 after purchasing an additional 2,000 shares in the last quarter. Bank of America Corp DE boosted its position in KMG Chemicals by 3.7% during the second quarter. Bank of America Corp DE now owns 60,324 shares of the specialty chemicals company’s stock valued at $4,451,000 after purchasing an additional 2,175 shares in the last quarter. Finally, Tower Research Capital LLC TRC bought a new stake in KMG Chemicals during the third quarter valued at about $171,000. 83.98% of the stock is currently owned by institutional investors and hedge funds.

KMG stock remained flat at $$76.14 during midday trading on Wednesday. The company has a current ratio of 2.62, a quick ratio of 1.71 and a debt-to-equity ratio of 0.74. KMG Chemicals has a twelve month low of $50.67 and a twelve month high of $79.35. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 0.58 and a beta of 0.48.

KMG Chemicals (NYSE:KMG) last released its earnings results on Thursday, October 18th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.28. KMG Chemicals had a return on equity of 16.69% and a net margin of 13.93%. Analysts forecast that KMG Chemicals will post 4.64 EPS for the current year.

KMG Chemicals Company Profile

KMG Chemicals, Inc, through its subsidiaries, manufactures, formulates, and distributes specialty chemicals and performance materials worldwide. The company's Electronic Chemicals segment is involved in the sale of high purity process chemicals primarily to etch and clean silicon wafers in the production of semiconductors, photovoltaics, and flat panel displays.

Recommended Story: Balanced Fund

Analyst Recommendations for KMG Chemicals (NYSE:KMG)

Receive News & Ratings for KMG Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KMG Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.